During the forecast period, the Hematology Diagnostics Market will exhibit profitable growth.
The global hematology diagnostics market is rapidly expanding; it was worth $3,167.2 million in 2017 and is expected to reach $5,288.3 million by 2026. Increasing blood donation procedures and rising incidences of blood disorders, along with enhanced diagnostics and hematology testing technologies, drive the overall hematology diagnostics market's growth.
A new technological evolution in automated hematology analyzers would also drive the overall market. Additionally, new standardized, automated sample collection, data processing, identification and testing, and ordering of new tests, among other processes, will further spur revenue growth during the forecast period.
Market Synopsis
The hematology consumables segment is expected to dominate the global market during the forecast period.
Overall, sales of hematology consumables are expanding significantly on a global scale. It is anticipated to continue its dominance during the forecast period. Rising demand for consumables, along with the diagnosis of blood disorders and other infections, will grow prominently.
Moreover, increasing volumes of diagnostic tests owing to growing awareness and incidence are also driving the market growth. A wide range of reagents and kits, stains, and others in the consumables segment incorporates experts to meet the dynamic demand.
The instrument segment is further divided into analyzers, flow cytometers, and others. Increased automation, which offers high reliability, sensitivity, and specificity along with higher safety and ease of operation, is estimated to be the primary growth factor driving the hematology instruments segment globally.
The diagnostic laboratories segment is expected to register higher growth by the end of 2026.
Diagnostic laboratories in the end-user segment are predicted to expand at a significant CAGR during the forecast period. The rising number of multispecialty diagnostic centers and the availability of advanced hematology products are fueling demand globally. Additionally, the automation of diagnostic tools is anticipated to reduce the overall cost of blood testing.
The rise in partnerships among market players and diagnostic laboratories is one factor that is likely to drive market growth. The adoption of fully automated analyzers, along with enhanced prognosis, infectious disease monitoring, diagnosis, and preliminary screening processes, will drive growth in the end-user segment.
Increasing demand for advanced equipment and the presence of established players hold North America in a dominant position.
North America will account for the largest revenue share of the global hematology diagnostics market. The use of advanced technologies for point-of-care tests, as well as rising incidences of diseases such as blood cancers, acute infectious diseases, liver diseases, and spleen diseases, are factors boosting growth in North America.
Asia Pacific is expected to grow at a significant pace owing to new technology expansion and the adoption of advanced diagnostic instruments. Enhanced healthcare services, along with improved government initiatives, will have a positive impact on the hematology diagnostics market.
The dominance of multinational manufacturers with strong product portfolios in the developed regions
Major players in the hematology diagnostics market are Abbott Laboratories, Bio-Rad Laboratories, Inc., Siemens Healthineers, Mindray Medical International Limited, Danaher Corporation, Hoffmann-La Roche Ltd., Nihon Kohden Corporation, Drew Scientific, Sysmex Corporation, EKF Diagnostics, Boule Diagnostics, HORIBA, Diatron MI Zrt., and others. Furthermore, new product launches and technology expansion in diagnostic laboratories will drive market growth in the future.
The rising prevalence of blood disorders and other target diseases, the dynamic shift from manual to automated hematology testing, and the competitive advantages offered by commercial service providers in developing countries will all contribute to the market's overall growth on a global scale.
Periods of History and Forecast
This study report includes an analysis for each segment from 2016 to 2026, with 2017 as the base year. The compound annual growth rate (CAGR) for each of the respective segments is estimated for the forecast period from 2018 to 2026.
Report Scope by Segment
The current report also includes qualitative and quantitative market valuation factors such as key market drivers, market trends, restraints, and opportunities to provide a more comprehensive understanding of the global hematology diagnostics market. Additionally, the global report also comprises a graphical representation of the competitive landscape based on their market initiatives and strategies, product portfolios, and business strengths.
Key questions are answered in this report.
- What are the current market trends and dynamics in the hematology diagnostics market, and what are the valuable opportunities for emerging players?
- How has laboratory automation affected the dynamics of the hematology diagnostics market?
- What are the impact of fully automated analyzers and their consumption in developed markets?
- Which segment accounts for the fastest CAGR during the forecast period?
- What is the impact of target diseases and other infectious diseases on the hematology diagnostics market?
- What are the market trends and dynamics in emerging markets such as India, Mexico, China, South Africa, Brazil, and the Gulf nations?
Request a Free Sample
Fill in your details and we'll send you a free sample report.
- Sample data tables & charts
- Research methodology
Market Dynamics
Rising Incidence of Blood Disorders
The increasing prevalence of blood disorders such as anemia, leukemia, and hemophilia is driving demand for advanced hematology diagnostics, as early and accurate detection is critical for effective treatment.
Technological Advancements in Automation
The evolution of automated hematology analyzers and standardized sample processing has improved test accuracy, throughput, and efficiency, making diagnostics more accessible and reliable for healthcare providers.
Growth in Blood Donation and Screening Procedures
A global rise in blood donation activities and the need for rigorous screening to ensure blood safety are fueling the demand for hematology testing and consumables.
Expansion of Diagnostic Laboratories
The proliferation of multispecialty diagnostic centers, especially in emerging markets, and the adoption of advanced hematology products are expanding the market's reach and capacity.
Government Initiatives and Healthcare Infrastructure Development
Improved healthcare infrastructure and supportive government policies in regions like Asia Pacific are facilitating the adoption of advanced hematology diagnostics, further boosting market growth.
Need a Custom Version of This Report?
Tailor the scope, geography, or segments to your exact requirements.
- Custom geography or segment scope
- Direct access to our analyst team
Frequently Asked Questions
What is the size of Hematology Diagnostics Market?
What is the Hematology Diagnostics Market CAGR?
What is the Forecast period considered for Hematology Diagnostics Market?
What is the base year considered for Hematology Diagnostics Market?
Who are the major players in this market?
Table of Content
Chapter 1 Market Segmentation
- 1.1 Segmentation Framework
- 1.1.1 Product and Service Classification
- 1.1.2 Application and End-Use Classification
- 1.1.3 Technology and Solution Classification
- 1.1.4 Customer and Distribution Channel Classification
- 1.1.5 Geographic Segmentation
- 1.1.6 Market Segment Definitions and Boundaries
- 1.2 By Product
- 1.2.1 Consumables
- 1.2.2 Instruments (Analyzers)
- 1.2.3 Flow Cytometers
- 1.2.4 Others
- 1.3 By End User
- 1.3.1 Diagnostic Laboratories
- 1.3.2 Hospitals
- 1.3.3 Academic & Research Institutes
- 1.3.4 Blood Banks
- 1.4 By Test Type
- 1.4.1 Complete Blood Count (CBC)
- 1.4.2 Hemoglobin Testing
- 1.4.3 Coagulation Testing
- 1.4.4 Others
Chapter 2 Introduction
- 2.1 Report Objectives and Scope
- 2.2 Product Definition and Industry Terminology
- 2.3 Market Inclusions and Exclusions
- 2.4 Research Process
- 2.4.1 Primary Research and Expert Interviews
- 2.4.2 Secondary Research and Source Review
- 2.4.3 Top-Down and Bottom-Up Estimation
- 2.4.4 Data Triangulation and Verification
- 2.5 Market Size Measurement Basis
- 2.5.1 Base year: USD 4,390.57 million → Forecast year: USD 8,397.79 million
- 2.6 Research Assumptions and Limitations
Chapter 3 Executive Summary
- 3.1 Market Snapshot and Key Findings
- 3.2 Base-Year Market Size
- 3.3 Forecast Market Size
- 3.4 Revenue and Volume Growth Outlook
- 3.5 Key Demand and Supply Indicators
- 3.6 Leading Market Segments
- 3.7 Fastest-Growing Market Opportunities
- 3.8 Regional Performance Highlights
- 3.9 Technology and Industry Transformation
- 3.10 Competitive Landscape Summary
- 3.11 Analyst View and Strategic Implications
Chapter 4 Global Hematology Diagnostics Market Trends and Developments
- 4.1 Historical Industry Development
- 4.2 Recent Market Trends and Developments
- 4.3 Demand and Customer Behavior Trends
- 4.4 Technology and Product Innovation
- 4.5 Artificial Intelligence, Automation and Digitalization
- 4.6 Local Manufacturing and Supply Chain Realignment
- 4.7 Industry Partnerships, Mergers and Acquisitions
- 4.8 Sustainability and Circular Economy Developments
- 4.9 Government and Private Sector Investment Trends
- 4.10 Emerging Business Models and Commercialization
- 4.11 Industry Developments and Announcements
Chapter 5 Global Hematology Diagnostics Market Production, Supply and Demand Analysis
- 5.1 Demand Trend and Consumption Analysis
- 5.2 Demand Forecast
- 5.3 Production and Output Trend
- 5.4 Production and Output Forecast
- 5.5 Installed Capacity and Capacity Utilization
- 5.6 Company-Wise Production Plants and Statistics
- 5.6.1 Installed Production Capacity
- 5.6.2 Actual Production
- 5.6.3 Planned Capacity and Expansion Targets
- 5.7 Supply Chain Structure and Procurement Trends
- 5.8 Supply-Demand Gap and Bottlenecks
- 5.9 Import Dependence and Sourcing Structure
- 5.10 Contract Manufacturing and Outsourcing
- 5.11 Regional Supply and Demand Concentration
Chapter 6 Global Hematology Diagnostics Market Pricing Analysis
- 6.1 Pricing Structure and Measurement
- 6.2 Historical Pricing Trends
- 6.3 Pricing Outlook
- 6.4 Average Selling Price and Unit Economics
- 6.5 Pricing by Product and Market Segment
- 6.6 Geographic Pricing Differences
- 6.7 Key Input, Energy, Labor and Logistics Costs
- 6.8 Contract Pricing and Purchasing Models
- 6.9 Pricing Sensitivity and Competitive Positioning
- 6.10 Price, Margin and Profitability Implications
Chapter 7 Global Hematology Diagnostics Market Dynamics
- 7.1 Market Growth Drivers
- 7.1.1 Demand-Side Drivers
- 7.1.2 Technology and Innovation Drivers
- 7.1.3 Infrastructure and Investment Drivers
- 7.1.4 Regulatory and Policy Drivers
- 7.2 Market Restraints
- 7.2.1 Cost and Affordability Constraints
- 7.2.2 Technology and Adoption Barriers
- 7.2.3 Supply Chain and Operational Constraints
- 7.3 Market Challenges
- 7.3.1 Competitive Pressure and Margin Erosion
- 7.3.2 Skills, Infrastructure and Implementation Gaps
- 7.4 Emerging Market Opportunities
- 7.5 Market Dynamics Impact and Time-Horizon Assessment
Chapter 8 Global Hematology Diagnostics Value Chain Analysis
- 8.1 Industry Value Chain Overview
- 8.2 Upstream Suppliers and Critical Inputs
- 8.3 Technology and Component Providers
- 8.4 Manufacturing or Service Delivery
- 8.5 Distribution, Channel Partners and Integrators
- 8.6 Downstream Applications and End Users
- 8.7 Value Addition and Profit Pools
- 8.8 Vertical Integration and Outsourcing
- 8.9 Supplier Concentration and Risk
- 8.10 Supply Chain Localization and Resilience
Chapter 9 Global Hematology Diagnostics Market Regulations and Policies
- 9.1 Relevant Laws, Standards and Compliance Frameworks
- 9.2 Product, Service, Safety and Quality Requirements
- 9.3 Government Policies, Incentives and Subsidies
- 9.4 Imports, Exports and Trade Barriers
- 9.5 Public Procurement and Local Content Requirements
- 9.6 Environmental and Sustainability Compliance
- 9.7 Upcoming Policy Changes and Market Implications
Chapter 10 Global Hematology Diagnostics Market Hotspots and Opportunities
- 10.1 Market Opportunity Mapping and Growth Hotspots
- 10.2 High-Growth Applications and Customer Groups
- 10.3 Underserved Markets and White-Space Opportunities
- 10.4 Emerging Technology and Product Opportunities
- 10.5 New Capacity and Investment Hotspots
- 10.6 Market Entry and Expansion Opportunities
- 10.7 Distribution and Partnership Opportunities
- 10.8 Near-Term and Long-Term Commercial Potential
- 10.9 Opportunity Attractiveness and Execution Risks
Chapter 11 Global Hematology Diagnostics Market Outlook
- 11.1 Market Size and Analysis
- 11.1.1 Revenue (Market Measurement: Base year: USD 4,390.57 million → Forecast year: USD 8,397.79 million)
- 11.1.2 Market Volume and Quantity Sold
- 11.1.3 Historical Market Size
- 11.1.4 Base-Year Market Size
- 11.2 Market Forecast
- 11.2.1 Revenue Forecast
- 11.2.2 Volume Forecast
- 11.2.3 CAGR and Year-on-Year Growth
- 11.2.4 Incremental Revenue Opportunity
- 11.3 Forecast Assumptions and Scenario Analysis
- 11.3.1 Base-Case Forecast
- 11.3.2 Optimistic and Conservative Scenarios
- 11.3.3 Technology, Pricing and Policy Sensitivities
- 11.4 Market Attractiveness and Growth Outlook
Chapter 12 Global Hematology Diagnostics Market Segmentation and Outlook
- 12.1 Segmentation Summary and Market Shares
- 12.2 Largest and Fastest-Growing Segments
- 12.3 By Product - Market Size and Forecast
- 12.3.1 Segment Definition and Scope
- 12.3.2 Historical Market Size
- 12.3.3 Revenue Forecast
- 12.3.4 Volume Forecast
- 12.3.5 Base-Year Market Share
- 12.3.6 Segment CAGR and Growth Drivers
- 12.3.7 Subsegment Market Size and Forecast
- 12.3.7.1 Consumables
- 12.3.7.2 Instruments (Analyzers)
- 12.3.7.3 Flow Cytometers
- 12.3.7.4 Others
- 12.3.8 Subsegment Pricing and Adoption Trends
- 12.3.9 Leading Suppliers and Competition
- 12.3.10 Regional Demand and Opportunities
- 12.4 By End User - Market Size and Forecast
- 12.4.1 Segment Definition and Scope
- 12.4.2 Historical Market Size
- 12.4.3 Revenue Forecast
- 12.4.4 Volume Forecast
- 12.4.5 Base-Year Market Share
- 12.4.6 Segment CAGR and Growth Drivers
- 12.4.7 Subsegment Market Size and Forecast
- 12.4.7.1 Diagnostic Laboratories
- 12.4.7.2 Hospitals
- 12.4.7.3 Academic & Research Institutes
- 12.4.7.4 Blood Banks
- 12.4.8 Subsegment Pricing and Adoption Trends
- 12.4.9 Leading Suppliers and Competition
- 12.4.10 Regional Demand and Opportunities
- 12.5 By Test Type - Market Size and Forecast
- 12.5.1 Segment Definition and Scope
- 12.5.2 Historical Market Size
- 12.5.3 Revenue Forecast
- 12.5.4 Volume Forecast
- 12.5.5 Base-Year Market Share
- 12.5.6 Segment CAGR and Growth Drivers
- 12.5.7 Subsegment Market Size and Forecast
- 12.5.7.1 Complete Blood Count (CBC)
- 12.5.7.2 Hemoglobin Testing
- 12.5.7.3 Coagulation Testing
- 12.5.7.4 Others
- 12.5.8 Subsegment Pricing and Adoption Trends
- 12.5.9 Leading Suppliers and Competition
- 12.5.10 Regional Demand and Opportunities
- 12.6 Segment Growth Comparison
- 12.7 Segment Attractiveness and Priority Matrix
Chapter 13 Global Hematology Diagnostics End-Use and Application Market Outlook
- 13.1 End-Use Industry and Customer Demand Structure
- 13.2 Leading Applications and Customer Groups
- 13.3 End-Use Market Size, Share and Forecast
- 13.4 Major End-Use Industry Deep Dives
- 13.4.1 Customer Requirements and Use Cases
- 13.4.2 Demand and Replacement Cycles
- 13.4.3 Technical and Regulatory Considerations
- 13.4.4 Purchasing and Procurement Models
- 13.4.5 Leading Vendors and Distribution Channels
- 13.4.6 Forecast and Commercial Opportunities
- 13.5 Emerging Applications and Cross-Segment Demand
- 13.6 End-Use Industry Investment Priorities
Chapter 14 Global Hematology Diagnostics Geographic Market Outlook
- 14.1 Regional Market Size and Share
- 14.2 Regional Market Forecast
- 14.3 Regional Pricing, Production and Demand Differences
- 14.4 North America
- 14.4.1 United States
- 14.4.2 Canada
- 14.4.3 Mexico
- 14.5 Europe
- 14.5.1 Germany
- 14.5.2 France
- 14.5.3 Italy
- 14.5.4 United Kingdom
- 14.5.5 Spain
- 14.5.6 Poland
- 14.5.7 Russia
- 14.5.8 Netherlands
- 14.5.9 Belgium
- 14.5.10 Sweden
- 14.5.11 Denmark
- 14.5.12 Norway
- 14.5.13 Rest of Europe
- 14.6 Asia Pacific
- 14.6.1 China
- 14.6.2 India
- 14.6.3 Japan
- 14.6.4 South Korea
- 14.6.5 Thailand
- 14.6.6 Indonesia
- 14.6.7 Vietnam
- 14.6.8 Malaysia
- 14.6.9 Australia
- 14.6.10 Rest of Asia Pacific
- 14.7 Latin America
- 14.7.1 Brazil
- 14.7.2 Argentina
- 14.7.3 Colombia
- 14.7.4 Chile
- 14.7.5 Rest of Latin America
- 14.8 Middle East
- 14.8.1 Saudi Arabia
- 14.8.2 United Arab Emirates
- 14.8.3 Turkey
- 14.8.4 Israel
- 14.8.5 Iran
- 14.8.6 Rest of the Middle East
- 14.9 Africa
- 14.9.1 South Africa
- 14.9.2 Egypt
- 14.9.3 Nigeria
- 14.9.4 Morocco
- 14.9.5 Rest of Africa
- 14.10 Regional Investment, Policy and Supply Chain Differences
- 14.11 Regional Competitive Landscape
- 14.12 Geographic Growth Hotspots
Chapter 15 Global Hematology Diagnostics Technology, Innovation and Sustainability Outlook
- 15.1 Technology Landscape and Maturity
- 15.2 Product, Process and Service Innovation
- 15.3 AI, Automation and Digital Tools in the Industry
- 15.4 Technology Adoption and Performance Benchmarking
- 15.5 Innovation Pipeline and R&D Investment
- 15.6 Patent and Intellectual Property Trends
- 15.7 Energy Efficiency and Resource Management
- 15.8 Sustainability, Recycling and Circularity
- 15.9 Technology Roadmap
- 15.10 Risks of Obsolescence and Technology Substitution
Chapter 16 Global Hematology Diagnostics Market Key Strategic Imperatives
- 16.1 Growth and Market Entry Priorities
- 16.2 High-Return Products and Segments
- 16.3 Pricing, Profitability and Cost Optimization
- 16.4 Technology Investment and Product Differentiation
- 16.5 Supply Chain Localization and Resilience
- 16.6 Distribution and Customer Acquisition
- 16.7 Partnership, Acquisition and Capacity Strategy
- 16.8 Regional Expansion Priorities
- 16.9 Short-, Medium- and Long-Term Actions
Chapter 17 Competition Outlook
- 17.1 Industry Competition Characteristics
- 17.2 Market Structure and Concentration
- 17.3 Market Share and Competitive Positioning
- 17.4 Company-Wise Revenue and Product Benchmarking
- 17.5 Production and Service Capacity Benchmarking
- 17.6 Technology, Pricing and Differentiation
- 17.7 Regional Footprint and Distribution Strength
- 17.8 Mergers, Acquisitions and Strategic Alliances
- 17.9 New Entrants and Competitive Threats
- 17.10 Porter's Five Forces and Industry Attractiveness
- 17.11 Competitive Outlook
Chapter 18 Company Profiles
- 18.1 Company Coverage and Selection Criteria
- 18.2 Abbott Laboratories
- 18.2.1 Business Description
- 18.2.2 Company Ownership and Geographic Presence
- 18.2.3 Product and Service Portfolio
- 18.2.4 Manufacturing and Operating Footprint
- 18.2.5 Production Capacity and Expansion Plans
- 18.2.6 Financial Performance and Investment
- 18.2.7 Market Share and Competitive Position
- 18.2.8 Technology and Innovation Capabilities
- 18.2.9 Strategic Alliances or Partnerships
- 18.2.10 Recent Developments
- 18.2.11 Growth Strategy and Outlook
- 18.3 Bio-Rad Laboratories, Inc.
- 18.4 Siemens Healthineers
- 18.5 Mindray Medical International Limited
- 18.6 Danaher Corporation
- 18.7 Hoffmann-La Roche Ltd.
- 18.8 Nihon Kohden Corporation
- 18.9 Sysmex Corporation
- 18.10 HORIBA
- 18.11 EKF Diagnostics
- 18.12 Other Relevant Market Participants
Note: Every listed company is profiled on the structure shown under the first company. The company list is preliminary and may change based on research findings, market developments, data availability and client requirements.
Chapter 19 Disclaimer
- 19.1 Research and Forecast Disclaimer
- 19.2 Data Source and Estimation Limitations
Note: The depth of individual sections depends on data availability for this market. Volume, capacity, trade and other unit-based metrics are included where applicable.
